Intermediate
Technical
IVT
AML
Also written as: AML — Acute Myeloid Leukemia
Acute myeloid leukemia, a blood cancer affecting myeloid cells that requires different treatment than ALL.
Full Definition
Acute myeloid leukemia (AML) represents approximately 20% of childhood leukemias and affects myeloid stem cells in the bone marrow. Unlike ALL, AML has different cytogenetic markers, treatment protocols, and prognosis in pediatric patients. The distinction between ALL and AML is critical for treatment planning and must be accurately documented in all clinical communications. AML subtypes are classified using FAB or WHO classification systems.
Usage
Usage note: Distinguish clearly from ALL in all documentation.
In Context
- "The bone marrow biopsy confirmed AML with t(8;21) translocation." — Pathology report
- "AML patients require more intensive chemotherapy than those with ALL." — Treatment protocol documentation
Also known as
acute myeloid leukemia
acute myelogenous leukemia
Contrasted with
ALL
chronic myeloid leukemia
Don't confuse with
ALL
chronic myeloid leukemia